Literature DB >> 17323112

Age and drug therapy are key prognostic factors for first clinical fracture in patients with primary osteoporosis.

O Gajic-Veljanoski1, R J Sebaldt, A M Davis, D Tritchler, G Tomlinson, A Petrie, J D Adachi, A M Cheung.   

Abstract

UNLABELLED: We evaluated the characteristics of 1,142 women and men who attended Canadian osteoporosis clinics and had T-score < or = -2.0 and no prior fractures to determine the predictors of first clinical fracture. Greater age and failure to start osteoporosis drug treatment increased the risk of first clinical fracture.
INTRODUCTION: Although risk factors for osteoporotic fractures are well-known, it is unclear which factors predict poor prognosis in patients with primary osteoporosis. The purpose of this study was to determine prognostic factors for first clinical fracture in patients with T-score < or = -2.0 and no previous clinical fracture.
METHODS: We examined prospectively collected data from 1,142 patients aged 40 and over in the Canadian Database of Osteoporosis and Osteopenia. We used prognosis methodology and performed survival analysis to determine factors that increase the risk of first clinical fracture.
RESULTS: Our inception cohort (mean age = 60.6 years, 91% females) had a cumulative fracture incidence of 5.1% (incidence rate: 2.53/100 person-years). Age and osteoporosis drug use predicted incident clinical fractures in multivariable regression analyses. The risk of first fracture increased by 3% per year. Failing to initiate osteoporosis treatment increased fracture risk by 2.4 times. In addition, low physical activity, high body mass index and low T-scores were found to predict fracture risk in certain patient subgroups using tree-structured survival analysis. These findings were robust and did not change with most sensitivity analyses.
CONCLUSION: Age and osteoporosis drug treatment are the main prognostic predictors of first clinical fracture in patients with T-score < or = -2.0.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17323112     DOI: 10.1007/s00198-007-0340-1

Source DB:  PubMed          Journal:  Osteoporos Int        ISSN: 0937-941X            Impact factor:   4.507


  47 in total

Review 1.  Osteoclast differentiation and activation.

Authors:  William J Boyle; W Scott Simonet; David L Lacey
Journal:  Nature       Date:  2003-05-15       Impact factor: 49.962

2.  Positive association between 25-hydroxy vitamin D levels and bone mineral density: a population-based study of younger and older adults.

Authors:  Heike A Bischoff-Ferrari; Thomas Dietrich; E John Orav; Bess Dawson-Hughes
Journal:  Am J Med       Date:  2004-05-01       Impact factor: 4.965

Review 3.  Practice databases and their uses in clinical research.

Authors:  W M Tierney; C J McDonald
Journal:  Stat Med       Date:  1991-04       Impact factor: 2.373

Review 4.  Secretory factors from human adipose tissue and their functional role.

Authors:  Hans Hauner
Journal:  Proc Nutr Soc       Date:  2005-05       Impact factor: 6.297

Review 5.  Multivariable prognostic models: issues in developing models, evaluating assumptions and adequacy, and measuring and reducing errors.

Authors:  F E Harrell; K L Lee; D B Mark
Journal:  Stat Med       Date:  1996-02-28       Impact factor: 2.373

6.  Risk factors for proximal humerus, forearm, and wrist fractures in elderly men and women: the Dubbo Osteoporosis Epidemiology Study.

Authors:  T V Nguyen; J R Center; P N Sambrook; J A Eisman
Journal:  Am J Epidemiol       Date:  2001-03-15       Impact factor: 4.897

7.  Can historical and functional risk factors be used to predict fractures in community-dwelling older adults? development and validation of a clinical tool.

Authors:  C S Colón-Emeric; C F Pieper; M B Artz
Journal:  Osteoporos Int       Date:  2002-12       Impact factor: 4.507

8.  Automated variable selection methods for logistic regression produced unstable models for predicting acute myocardial infarction mortality.

Authors:  Peter C Austin; Jack V Tu
Journal:  J Clin Epidemiol       Date:  2004-11       Impact factor: 6.437

9.  Mortality after osteoporotic fractures.

Authors:  O Johnell; J A Kanis; A Odén; I Sernbo; I Redlund-Johnell; C Petterson; C De Laet; B Jönsson
Journal:  Osteoporos Int       Date:  2003-10-30       Impact factor: 4.507

10.  Bone mineral density thresholds for pharmacological intervention to prevent fractures.

Authors:  Ethel S Siris; Ya-Ting Chen; Thomas A Abbott; Elizabeth Barrett-Connor; Paul D Miller; Lois E Wehren; Marc L Berger
Journal:  Arch Intern Med       Date:  2004-05-24
View more
  2 in total

1.  Undertreatment of osteoporosis in the oldest old? A nationwide study of over 700,000 older people.

Authors:  Kristina Johnell; Johan Fastbom
Journal:  Arch Osteoporos       Date:  2009-03-19       Impact factor: 2.617

2.  Sustained efficacy of risedronate in men with primary and secondary osteoporosis: results of a 2-year study.

Authors:  Johann D Ringe; Parvis Farahmand; Herbert Faber; Alfred Dorst
Journal:  Rheumatol Int       Date:  2008-09-02       Impact factor: 2.631

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.